Bandingkan Harga & Kinerja Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Summarecon Agung Tbk. (SMRA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Summarecon Agung Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M), sedangkan Summarecon Agung Tbk. diperdagangkan di Rp322 (kapitalisasi pasar 5,32 T). Perbedaan utamanya: Summarecon Agung Tbk. jauh lebih besar — sekitar 30,8× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SMRA | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 5,32 T |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →Tentang Summarecon Agung Tbk.
PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Selengkapnya di halaman SMRA →
